Estudo da qualidade de vida de usuários crônicos de medicações psiquiátricas de um serviços de saúde de João Pessoa –PB

• Autor(a) principal: Batista Júnior, Luis Carlos Vieira
• Data de Publicação: 2022
• Tipo de documento: Trabalho de conclusão de curso
• Idioma: por
• Título da fonte: Repositório do Centro Universitário Braz Cubas
• Texto Completo: https://repositorio.cruzeirodosul.edu.br/handle/123456789/4175
• topic: atenção primária à saúde; psicotrópicos; qualidade de vida; CNPQ::CIENCIAS DA SAUDE::MEDICINA

The use of psychotropic drugs represents a significant portion of the total number of prescription drugs in Brazil. Studies show that only a portion of patients undergoes their treatments according to the guidelines, generating inadequacies and inconsistencies in the prescriptions of psychotropic drugs in Primary Health Care services, leading to a decrease in the quality of life of patients assisted due to the chronic use of these medications. Studies show that the use of non-pharmacological therapies (NPT) improves the quality of life of patients. The problem of this study was the fact that the chronic use of psychotropic drugs impacts the quality of life of users and the costs to the state. The objective of this study was to analyze the quality of life of users of a Primary Health Care service in João Pessoa-PB who make exclusive use of psychiatric medications in a chronic way and of those who make this use associated with NPT. It was an observational, field, cross-sectional study with a quantitative approach. The research was carried out from January to April 2022, the sample consisted of 44 users, of all genders, aged 18 to 80 years. Data collection took place in person through the questionnaire on sociodemographic aspects and NPT of chronic users of psychiatric medications and the WHOQOL –BREF instrument. For statistical analysis, calculations of frequencies, average, standard deviation, independent t-test for comparison and chi-square test for association were performed, considering statistically significant values p<0.05. Data were presented in the form of graphs and tables. The study was approved by the Research Ethics Committee of the Centro Universitário de João Pessoa and approved under CAAE 54362421.0.0000.5176. Of the sample, 77.3% make exclusive use of pharmacological therapies (group 1) and 22.7% make use of these therapies associated with NPT (group2). The t-test showed that the average quality of life of users in group 1 was higher than in group 2 and that there was statistical significance in domains 2 and 3, contrary to the data found in the literature. There was no association between NPT use and socioeconomic status; educational level; age and gender when testing the association between chi-square variables. It was concluded that most of the studied sample did not use NPT; there was no statistical significance between the comparison of the meansof the answers to the quality of life questionnaire of the groups; there was no association between the use of NPT and the sociodemographic parameters evaluated.